1
|
Salem R, Lewandwoski R. Abstract No. 75 Carcinoembryonic Antigen, Tumor Response and Quality of Life with Glass Transarterial Radioembolization (TARE) in Liver-Dominant Metastatic Colorectal Cancer Patients: Results from the EPOCH Trial. J Vasc Interv Radiol 2023. [DOI: 10.1016/j.jvir.2022.12.121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/26/2023] Open
|
2
|
Goyal P, Jenkins K, Hohlastos E, Salem R, Mouli S. Abstract No. 283 Impact of Repeat Prostate Artery Embolization on Sexual Function. J Vasc Interv Radiol 2023. [DOI: 10.1016/j.jvir.2022.12.350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/27/2023] Open
|
3
|
Malik A, Strolia I, Moazeni Y, Patel M, Salem R, Riaz A. Abstract No. 567 Safety and Efficacy of Percutaneous Management of Acute Cholangitis. J Vasc Interv Radiol 2023. [DOI: 10.1016/j.jvir.2022.12.425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/27/2023] Open
|
4
|
Goyal P, Jenkins K, Salem R, Mouli S. Abstract No. 281 Impact of Pre-Procedural Medications on Prostate Artery Embolization Outcomes. J Vasc Interv Radiol 2023. [DOI: 10.1016/j.jvir.2022.12.348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/27/2023] Open
|
5
|
Brahmandam A, Grubman S, Salem R, Davis KA, Tonnessen BH, Guzman RJ, Ochoa Chaar CI. Placement and retrieval of bilateral iliac vein filters in patients with mega cava. J Vasc Surg Cases Innov Tech 2022; 8:610-615. [PMID: 36248380 PMCID: PMC9556588 DOI: 10.1016/j.jvscit.2022.08.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2022] [Revised: 07/26/2022] [Accepted: 08/04/2022] [Indexed: 01/05/2023] Open
Abstract
Temporary interruption of the inferior vena cava is the recommended treatment to prevent pulmonary embolism in patients with venous thromboembolism (VTE) and active contraindications for therapeutic anticoagulation. In patients with mega cava (diameter >30 mm), temporary inferior vena cava filters are contraindicated. In the present report, we have described the successful placement and retrieval of bilateral iliac vein filters in two patients with VTE, mega cava, and active contraindications for therapeutic anticoagulation. At the last follow-up, both patients had recovered without recurrent VTE and had had all filters successfully retrieved without complications.
Collapse
Affiliation(s)
- Anand Brahmandam
- Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Yale University School of Medicine, New Haven, CT
| | | | - Ronald Salem
- Division of Surgical Oncology, Department of Surgery, Yale University School of Medicine, New Haven, CT
| | - Kimberly A. Davis
- Division of General Surgery, Trauma, and Surgical Critical Care, Department of Surgery, Yale University School of Medicine, New Haven, CT
| | - Britt H. Tonnessen
- Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Yale University School of Medicine, New Haven, CT
| | - Raul J. Guzman
- Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Yale University School of Medicine, New Haven, CT
| | - Cassius Iyad Ochoa Chaar
- Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Yale University School of Medicine, New Haven, CT
- Correspondence: Cassius Iyad Ochoa Chaar, MD, MS, Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Yale University School of Medicine, 330 Cedar St, Boardman 204B, New Haven, CT 06510
| |
Collapse
|
6
|
Grada A, Barbieri J, Armstrong A, Salem R, Feldman S. 376 Trends in oral antibiotic use for acne treatment: A population-based study in the United States, 2014-2016. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
7
|
Savoor R, Gordon A, Hohlastos E, Desai K, Sato K, Salem R, Lewandowski R. Abstract No. 563 Yttrium-90 radiation segmentectomy for neuroendocrine tumor liver metastases. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.545] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
8
|
Salem R, Garin E, Fowers K, Mahvash A, Padia S, Mulcahy M. Abstract No. 243 Treatment Timing and Overall Survival of Liver-Dominant Metastatic Colorectal Cancer Patients Treated with Glass Transarterial Radioembolization: Analyses from the EPOCH Trial. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
9
|
Aguiar J, Soliman M, Malik A, Antalek M, Lewandowski R, Thornburg B, Salem R, Riaz A. Abstract No. 567 Percutaneous biliary interventions in the management of malignant obstructions: 277-patient analysis. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.549] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
10
|
Sperry C, Reilland A, Malik A, Thornburg B, Salem R, Riaz A. Abstract No. 566 Percutaneous cystic duct interventions to internalize percutaneous cholecystostomy drains for non-surgical calculous cholecystitis patients. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
11
|
Xiao N, Aggarwal R, Soliman M, Lewandowski R, Karp J, Salem R, Hohlastos E, Desai K. Abstract No. 162 Medium and long-term outcomes of single session inferior vena cava filter removal, recanalization and endovenous reconstruction for filter-related chronic iliocaval thrombosis. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
12
|
Gordon A, Patel M, Gabr A, Riaz A, Hohlastos E, Gupta R, Salem R, Lewandowski R. Abstract No. 195 Tumor size is an independent risk factor for mortality after yttrium-90 radioembolization for HCC. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.276] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
13
|
Entezari P, Badar W, Malik A, Ahmed O, Salem R, Riaz A. Abstract No. 84 Impact of portal hypertension on outcomes of splenic arterial aneurysm embolization: a multi-institutional analysis. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
14
|
Talwar A, Varghese J, Knight G, Katariya N, Caicedo-Ramirez J, Dietch Z, Borja-Cacho D, Ladner D, Christopher D, Baker T, Abecassis M, Mouli S, Desai K, Riaz A, Thornburg B, Salem R. Abstract No. 184 Pre-operative portal vein recanalization-transjugular intrahepatic portosystemic shunt for chronic, obliterative portal vein thrombosis: outcomes following liver transplantation. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
15
|
Soliman M, Malik A, Aguiar J, Antalek M, Salem R, Riaz A. Abstract No. 228 Single-institution retrospective review of percutaneous transhepatic image and cholangioscopy guided biliary interventions. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
16
|
Ranganathan S, Entezari P, Gabr A, Gordon A, Kulik L, Desai K, Thornburg B, Riaz A, Salem R, Lewandowski R. Abstract No. 309 Evaluating liver function status trends in hepatocellular carcinoma patients with intermediate-stage disease undergoing radioembolization: a longitudinal study. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
17
|
Soliman M, Malik A, Salem R, Riaz A. Abstract No. 574 Interventional radiology experience of performing primary retrograde urinary drainage using image and endoscopy guidance via urostomies. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
18
|
Xiao N, Lewandowski R, Karp J, Salem R, Desai K. Abstract No. 146 Risk factors for development of IVC thrombosis in inferior vena cava filter bearing patients. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
19
|
Xiao N, Genet M, Marquez R, Hohlastos E, Salem R, Karp J, Lewandowski R, Desai K. Abstract No. 155 Single-procedure, 8Fr rheolytic pharmacomechanical iliofemoral deep venous thrombectomy: a retrospective study of efficacy, safety and durability. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
20
|
Robins C, Xiao N, Salem R, Keswani R, Riaz A. Abstract No. 227 Percutaneous biliary neo-anastomosis creation using radiofrequency wires. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
21
|
Gordon A, Thornburg B, Savoor R, Riaz A, Caicedo-Ramirez J, Kulik L, Boike J, Borhani A, Salem R, Lewandowski R. Abstract No. 229 Does spontaneous portosystemic shunt embolization improve liver transplantation outcomes? A propensity-score matched analysis. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
22
|
Soliman M, Malik A, Auffenberg G, Lewandowski RJ, Salem R, Riaz A. Primary retrograde urinary drainage using image and endoscopy guidance via urostomies. Clin Radiol 2022; 77:553-557. [PMID: 35550302 DOI: 10.1016/j.crad.2022.03.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2022] [Accepted: 03/25/2022] [Indexed: 11/17/2022]
Abstract
AIM To report the technical success of image and endoscopy-guided retrograde trans-urostomy urinary drainage as a primary catheter placement method performed by interventional radiology (IR). MATERIALS AND METHODS Nine patients (15 attempted drain placements) with ureteric obstruction following radical cystectomy and urostomy creation were included. The patients were referred to IR for urinary drainage. All patients underwent primary image and endoscopy-guided retrograde trans-urostomy urinary drainage. RESULTS Primary image and endoscopy-guided retrograde trans-urostomy urinary drainage was successful in 13/15 (86.6%) attempts. The proposed technique had a limited complication rate omitting the percutaneous nephrostomy access step. CONCLUSION Primary image and endoscopy guided retrograde trans-urostomy urinary drainage should be considered before percutaneous nephrostomy in all patients with a urostomy.
Collapse
Affiliation(s)
- M Soliman
- Department of Radiology, Section of Interventional Radiology, Northwestern Memorial Hospital, Chicago, IL, USA
| | - A Malik
- Department of Radiology, Section of Interventional Radiology, Northwestern Memorial Hospital, Chicago, IL, USA
| | - G Auffenberg
- Department of Urology, Northwestern Memorial Hospital, Chicago, IL, USA
| | - R J Lewandowski
- Department of Radiology, Section of Interventional Radiology, Northwestern Memorial Hospital, Chicago, IL, USA
| | - R Salem
- Department of Radiology, Section of Interventional Radiology, Northwestern Memorial Hospital, Chicago, IL, USA
| | - A Riaz
- Department of Radiology, Section of Interventional Radiology, Northwestern Memorial Hospital, Chicago, IL, USA.
| |
Collapse
|
23
|
Saffo S, Peng C, Salem R, Taddei T, Nagar A. Impact of Neoadjuvant Chemotherapy and Pretreatment Biliary Drainage for Pancreatic Head Ductal Adenocarcinoma. Dig Dis Sci 2022; 67:1409-1416. [PMID: 33811566 PMCID: PMC8487432 DOI: 10.1007/s10620-021-06967-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/25/2020] [Accepted: 03/18/2021] [Indexed: 02/04/2023]
Abstract
BACKGROUND Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related deaths in the USA. Although management strategies have evolved, there are continued controversies about the use of neoadjuvant chemotherapy (NAC) and pretreatment biliary drainage (PBD) in patients with resectable and potentially resectable disease. AIMS We aimed to characterize the practice trends and outcomes for NAC and PBD. METHODS A single-center cohort study was performed. Electronic medical records were reviewed between 2011 and 2019, and 140 patients who had pancreaticoduodenectomy for PDAC were included. Diagnosis, treatment, and outcome data were captured. RESULTS There were no statistically significant temporal trends relating to the use of chemotherapy and PBD. Overall, 41% of patients received NAC and had improved survival, independent of other factors. Of the 71% who received PBD, only 40% had appropriate indications; 30% experienced postprocedure complications, and 34% required reintervention. Factors associated with the application of PBD included preoperative jaundice (OR 70.5, 95% CI 21.4-306.6) and evaluation by non-tertiary therapeutic endoscopists (OR 3.9, 95% CI 1.3-13.6). PBD was associated with a 12-day delay in surgery among those who did not receive NAC (p = 0.005), but there were no differences in surgical complications or mortality. CONCLUSIONS Our findings suggest that (1) NAC may confer a survival benefit and (2) PBD should be reserved for individuals with jaundice requiring NAC. Implementation of guidelines by North American gastroenterology societies, multidisciplinary treatment models, and delivery of care at high-volume tertiary centers may help optimize management.
Collapse
Affiliation(s)
- Saad Saffo
- Section of Digestive Diseases, Yale University School of Medicine, 333 Cedar Street, 1080 LMP, New Haven, CT, 06520-8019, USA.
| | - Chengwei Peng
- Department of Hematology and Oncology, New York University Grossman School of Medicine, New York, NY, USA
| | - Ronald Salem
- Department of Surgery, Yale University School of Medicine, New Haven, CT, USA
| | - Tamar Taddei
- Section of Digestive Diseases, Yale University School of Medicine, 333 Cedar Street, 1080 LMP, New Haven, CT, 06520-8019, USA
- West Haven Veteran Affairs Medical Center, West Haven, CT, USA
| | - Anil Nagar
- Section of Digestive Diseases, Yale University School of Medicine, 333 Cedar Street, 1080 LMP, New Haven, CT, 06520-8019, USA
- West Haven Veteran Affairs Medical Center, West Haven, CT, USA
| |
Collapse
|
24
|
Brahmandam A, Grubman S, Salem R, Davis KA, Tonnessen BH, Guzman RJ, Ochoa Chaar CI. Placement and Retrieval of Bilateral Iliac Vein Filters in Patients With Mega Cava. J Vasc Surg 2021. [DOI: 10.1016/j.jvs.2021.07.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
25
|
Lam M, Salem R, Garin E. 934P The TARGET study: A global investigation of advanced dosimetry for transarterial radioembolization of hepatocellular carcinoma with yttrium-90 glass microspheres. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
26
|
Mulcahy M, Salem R, Mahvash A, Pracht M, Montazeri A, Bandula S, Hermann K, Brown E, Zuckerman D, Wilson G, Kim TY, Weaver A, Ross P, Harris W, Johnson M, Sofocleous C, Padia S, Lewandowski R, Garin E, Sinclair P. LBA21 Radioembolization with chemotherapy for colorectal liver metastases: A randomized, open-label, international, multicenter, phase III trial (EPOCH study). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.2095] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
27
|
Cohen R, Nikolaevsky M, Salem R, Frydman A. Setup for pressurizing thin films through the superconductor-insulator transition. Rev Sci Instrum 2021; 92:083903. [PMID: 34470441 DOI: 10.1063/5.0053906] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/13/2021] [Accepted: 07/25/2021] [Indexed: 06/13/2023]
Abstract
We describe an experimental setup designed for transport measurement of thin disordered superconducting films as a function of pressure up to several GPa. We use a specially designed single screw diamond anvil cell that allows the gradual increase of high pressure at cryogenic temperatures. By depositing amorphous films of disordered superconducting indium oxide directly on the diamond, we avoid the effect of pressure-induced structural changes in the substrate. Using this technique, we are able to drive thin films through a pressure tuned superconductor-insulator transition.
Collapse
Affiliation(s)
- R Cohen
- Department of Physics, Jack and Pearl Resnick Institute and the Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - M Nikolaevsky
- Department of Physics, Jack and Pearl Resnick Institute and the Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| | - R Salem
- Physics Department, Nuclear Research Centre - Negev, P.O. Box 9001, 84190 Beer Sheva, Israel
| | - A Frydman
- Department of Physics, Jack and Pearl Resnick Institute and the Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel
| |
Collapse
|
28
|
Modlin IM, Kidd M, Oberg K, Falconi M, Filosso PL, Frilling A, Malczewska A, Salem R, Toumpanakis C, Laskaratos FM, Partelli S, Roffinella M, von Arx C, Kudla BK, Bodei L, Drozdov IA, Kitz A. Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest). Ann Surg Oncol 2021; 28:7506-7517. [PMID: 34008138 DOI: 10.1245/s10434-021-10021-1] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2020] [Accepted: 03/31/2021] [Indexed: 12/12/2022]
Abstract
INTRODUCTION Surgery is the only cure for neuroendocrine tumors (NETs), with R0 resection being critical for successful tumor removal. Early detection of residual disease is key for optimal management, but both imaging and current biomarkers are ineffective post-surgery. NETest, a multigene blood biomarker, identifies NETs with >90% accuracy. We hypothesized that surgery would decrease NETest levels and that elevated scores post-surgery would predict recurrence. METHODS This was a multicenter evaluation of surgically treated primary NETs (n = 153). Blood sampling was performed at day 0 and postoperative day (POD) 30. Follow-up included computed tomography/magnetic resonance imaging (CT/MRI), and messenger RNA (mRNA) quantification was performed by polymerase chain reaction (PCR; NETest score: 0-100; normal ≤20). Statistical analyses were performed using the Mann-Whitney U-test, Chi-square test, Kaplan-Meier survival, and area under the receiver operating characteristic curve (AUROC), as appropriate. Data are presented as mean ± standard deviation. RESULTS The NET cohort (n = 153) included 57 patients with pancreatic cancer, 62 patients with small bowel cancer, 27 patients with lung cancer, 4 patients with duodenal cancer, and 3 patients with gastric cancer, while the surgical cohort comprised patients with R0 (n = 102) and R1 and R2 (n = 51) resection. The mean follow-up time was 14 months (range 3-68). The NETest was positive in 153/153 (100%) samples preoperatively (mean levels of 68 ± 28). In the R0 cohort, POD30 levels decreased from 62 ± 28 to 22 ± 20 (p < 0.0001), but remained elevated in 30% (31/102) of patients: 28% lung, 29% pancreas, 27% small bowel, and 33% gastric. By 18 months, 25/31 (81%) patients with a POD30 NETest >20 had image-identifiable recurrence. An NETest score of >20 predicted recurrence with 100% sensitivity and correlated with residual disease (Chi-square 17.1, p < 0.0001). AUROC analysis identified an AUC of 0.97 (p < 0.0001) for recurrence-prediction. In the R1 (n = 29) and R2 (n = 22) cohorts, the score decreased (R1: 74 ± 28 to 45 ± 24, p = 0.0012; R2: 72 ± 24 to 60 ± 28, p = non-significant). At POD30, 100% of NETest scores were elevated despite surgery (p < 0.0001). CONCLUSION The preoperative NETest accurately identified all NETs (100%). All resections decreased NETest levels and a POD30 NETest score >20 predicted radiologically recurrent disease with 94% accuracy and 100% sensitivity. R0 resection appears to be ineffective in approximately 30% of patients. NET mRNA blood levels provide early objective genomic identification of residual disease and may facilitate management.
Collapse
Affiliation(s)
| | - Mark Kidd
- Wren Laboratories, Branford, CT, USA
| | | | | | | | | | | | - Ronald Salem
- Yale University School of Medicine, New Haven, CT, USA
| | | | | | | | | | | | | | - Lisa Bodei
- Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | | | | |
Collapse
|
29
|
Lam M, Salem R, Garin E. Abstract No. LB02 A global study of advanced dosimetry in the treatment of hepatocellular carcinoma with Yttrium-90 glass microspheres: analyses from the TARGET study. J Vasc Interv Radiol 2021. [DOI: 10.1016/j.jvir.2021.03.096] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
30
|
Chiu A, Gordon A, Riaz A, Salem R, Lewandowski R. Abstract No. 71 Outcomes of segmental Yttrium-90 radioembolization in oligometastatic secondary hepatic malignancies. J Vasc Interv Radiol 2021. [DOI: 10.1016/j.jvir.2021.03.493] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
31
|
Mouli S, Raiter S, Burks M, Mylarapu A, Harris K, Lewandowski R, Hohlastos E, Salem R. Abstract No. 1 ▪ ABSTRACT OF THE YEAR Y90 radioembolization to the prostate gland: proof of concept in a canine model and clinical translation. J Vasc Interv Radiol 2021. [DOI: 10.1016/j.jvir.2021.03.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
32
|
Miccio J, Talcott W, Patel T, Park H, Cecchini M, Salem R, Stein S, Kortmansky J, Lacy J, Johung K, Jethwa K. The Utility of Neoadjuvant Radiotherapy after Neoadjuvant Multiagent Chemotherapy in Patients with Localized Pancreatic Cancer. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.02.538] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
33
|
Magulick JP, Salem R, Jamidar P. Intraoperative pancreatoscopy for surgical planning in a patient with ansa pancreatica and mixed-type intraductal pancreatic mucinous neoplasm. Gastrointest Endosc 2020; 92:968-970. [PMID: 32360408 DOI: 10.1016/j.gie.2020.04.052] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/29/2019] [Accepted: 04/23/2020] [Indexed: 02/08/2023]
Affiliation(s)
- John P Magulick
- Division of Digestive Diseases, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
| | - Ronald Salem
- Division of Surgical Oncology, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA
| | - Priya Jamidar
- Division of Digestive Diseases, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
| |
Collapse
|
34
|
Salem R, Johnson G, Riaz A, Bishav V, Kim E, Padia S. 992P Yttrium-90 glass microspheres in the treatment of early and advanced hepatocellular carcinoma: The LEGACY study. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1108] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
35
|
Errea M, Lewandowski R, Karp J, Salem R, Yang Y, Desai K. 3:00 PM Abstract No. 273 Device-specific adverse event rates of retrievable inferior vena cava filters after 90 days: a systematic review and network meta-analysis. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
36
|
Gabr A, Ranganathan R, Mouli S, Riaz A, Gates V, Desai K, Thornburg B, Lewandowski R, Salem R. 4:03 PM Abstract No. 29 Streamlining Y90 in early stage hepatocellular carcinoma by eliminating the lung shunt study: analysis of a 403-patient cohort. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
37
|
Joh M, Mutonga M, Li E, Riaz A, Mouli S, Kulik L, Lewandowski R, Salem R, Thornburg B. 4:03 PM Abstract No. 324 Survival comparison of patients undergoing elective transjugular intrahepatic portosystemic shunt creation with intermediate and high Model End Stage Liver Disease scores. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
38
|
Matsumoto M, Saxena P, Gabr A, Riaz A, Lewandowski R, Salem R, Mouli S. Abstract No. 563 The effect of deviating from Barcelona Clinic Liver Cancer treatment recommendations on outcomes and survival: an intention-to-treat analysis. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
39
|
Gabr A, Riaz A, Mouli S, Thornburg B, Desai K, Sato K, Salem R, Lewandowski R. 3:36 PM Abstract No. 26 Longitudinal study of progression patterns of hepatocellular carcinoma patients undergoing Y90 radiation segmentectomy. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
40
|
Xiao N, Lewandowski R, Karp J, Salem R, Ryu R, Desai K. 3:27 PM Abstract No. 276 Excimer laser sheath–assisted retrieval of “closed-cell” design inferior vena cava filters. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
41
|
Caldwell B, Gabr A, Sher A, Salem R, Kim E, Lewandowski R. 3:36 PM Abstract No. 141 Radioembolization for recurrent hepatocellular carcinoma after liver transplant: a multicenter exploratory analysis. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
42
|
Klepitsch E, Gupta R, Thornburg B, Lewandowski R, Salem R, Desai K. 3:54 PM Abstract No. 88 Safety and efficacy of Gianturco tracheobronchial z-stent placement for recanalization in patients with inferior vena cava occlusion. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
43
|
Morton C, Gabr A, Riaz A, Mouli S, Thornburg B, Desai K, Sato K, Salem R, Lewandowski R. Abstract No. 716 Long-term outcomes of Yttrium-90 radioembolization for hepatocellular carcinoma due to underlying non-alcoholic steatohepatitis. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.775] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
44
|
Klepitsch E, Gupta R, Thornburg B, Lewandowski R, Salem R, Desai K. 3:00 PM Abstract No. 82 Common femoral vein stent placement for postthrombotic iliofemoral occlusions: outcomes from a single-center experience. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
45
|
Xiao N, Pinkard J, Paranandi K, Antalek M, Salem R, Riaz A. 4:03 PM Abstract No. 106 Percutaneous transhepatic cholangiography with biliary intervention for unresectable malignant biliary obstruction following endoscopically placed stents. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
46
|
Gordon A, Gupta A, Gabr A, Thornburg B, Riaz A, Mouli S, Salem R, Lewandowski R. 3:54 PM Abstract No. 143 Segmental radioembolization for hepatocellular carcinoma is safe and effective after transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
47
|
Beardsley A, Knight G, Hohlastos E, Lewandowski R, Salem R, Mouli S. 3:45 PM Abstract No. 67 Prostate artery embolization with Bead Block microspheres for lower urinary tract symptoms from benign prostatic hyperplasia: Interim Results from a prospective FDA-Approved Investigational Device Exemption Study. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
48
|
Gabr A, Saxena P, Riaz A, Mouli S, Sato K, Salem R, Lewandowski R. 3:09 PM Abstract No. 138 Comparative outcome study of surgically resectable hepatocellular carcinoma patients versus those requiring neoadjuvant radioembolization prior to surgical resection. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
49
|
Beech C, Freedman-Weiss M, Salem R, Jain D, Zhang X. Pancreatic Intraductal Papillary Mucinous Neoplasm With Elevated Pre-Operative Cystic Carcinoembryonic Antigen Level: A Histopathologic Correlation. Gastroenterology Res 2019; 12:185-190. [PMID: 31523327 PMCID: PMC6731045 DOI: 10.14740/gr1201] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/07/2019] [Accepted: 07/16/2019] [Indexed: 12/18/2022] Open
Abstract
Background To study the relationship between carcinoembryonic antigen (CEA) level, intraductal papillary mucinous neoplasm (IPMN) subtype, and the presence of invasive carcinoma. Methods Cystic CEA level and the following pathologic variables: subtypes of IPMN, size of cystic lesion, presence of dysplasia or carcinoma, and main or branch duct involvement from 45 IPMN cases were analyzed. Results There was a significant correlation between pre-operative cystic fluid CEA level and the intensity of luminal CEA staining. However, there was no correlation between CEA level and cystic mucinous secretions or mucinous epithelial cytoplasm CEA staining, mucin glycoprotein expression, size of lesion, grade of dysplasia or presence of invasive carcinoma. CEA level was neither sensitive nor specific for the presence of invasive carcinoma. Conclusions Cystic CEA level may not be a reliable determinant of the presence or absence of invasive carcinoma in IPMNs, and its use to assess risk of malignancy may be limited.
Collapse
Affiliation(s)
- Cameron Beech
- Department of Pathology, Yale University School of Medicine, New Haven, CT, USA
| | - Mollie Freedman-Weiss
- Section of Surgical Oncology, Yale University School of Medicine, New Haven, CT, USA
| | - Ronald Salem
- Section of Surgical Oncology, Yale University School of Medicine, New Haven, CT, USA
| | - Dhanpat Jain
- Department of Pathology, Yale University School of Medicine, New Haven, CT, USA
| | - Xuchen Zhang
- Department of Pathology, Yale University School of Medicine, New Haven, CT, USA
| |
Collapse
|
50
|
Muniraj T, Salem R, Olave-Martinez M, Suarez A, Aslanian HR. Perforation of the duodenum 2 weeks after lumen-apposing metal stent placement for malignant pyloric stricture. Gastrointest Endosc 2019; 89:1069-1070. [PMID: 30639540 DOI: 10.1016/j.gie.2019.01.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/31/2018] [Accepted: 01/04/2019] [Indexed: 12/11/2022]
Affiliation(s)
| | - Ronald Salem
- Section of Surgical Oncology, Yale School of Medicine, New Haven, Connecticut, USA
| | | | | | - Harry R Aslanian
- Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut, USA
| |
Collapse
|